Park HY, Kim CE, Lee SM, Ahn JM, et al. Priming mesenchymal stem/stromal cells with a combination of a low dose of IFN-gamma and bortezomib results in potent suppression of pathogenic Th17 immunity through the IDO1-AHR axis. Stem Cells 2022 Oct 15. pii: 6761662. doi: 10.1093.
PMID: 36242771